237 related articles for article (PubMed ID: 22035749)
1. Older patients with acute myeloid leukemia benefit from intensive chemotherapy: an update from the Swedish Acute Leukemia Registry.
Juliusson G
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S54-9. PubMed ID: 22035749
[TBL] [Abstract][Full Text] [Related]
2. Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry.
Hulegårdh E; Nilsson C; Lazarevic V; Garelius H; Antunovic P; Rangert Derolf Å; Möllgård L; Uggla B; Wennström L; Wahlin A; Höglund M; Juliusson G; Stockelberg D; Lehmann S
Am J Hematol; 2015 Mar; 90(3):208-14. PubMed ID: 25421221
[TBL] [Abstract][Full Text] [Related]
3. Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.
Tran H; Yang D
Ann Pharmacother; 2012 Jan; 46(1):89-96. PubMed ID: 22170975
[TBL] [Abstract][Full Text] [Related]
4. Has there been progress in the treatment of older patients with acute myeloid leukemia?
Erba HP
Best Pract Res Clin Haematol; 2010 Dec; 23(4):495-501. PubMed ID: 21130413
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.
Juliusson G; Karlsson K; Lazarevic VLj; Wahlin A; Brune M; Antunovic P; Derolf A; Hägglund H; Karbach H; Lehmann S; Möllgård L; Stockelberg D; Hallböök H; Höglund M;
Cancer; 2011 Sep; 117(18):4238-46. PubMed ID: 21387283
[TBL] [Abstract][Full Text] [Related]
6. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
Ferrara F
Hematol Oncol; 2014 Mar; 32(1):1-9. PubMed ID: 23512815
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
8. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.
Juliusson G; Antunovic P; Derolf A; Lehmann S; Möllgård L; Stockelberg D; Tidefelt U; Wahlin A; Höglund M
Blood; 2009 Apr; 113(18):4179-87. PubMed ID: 19008455
[TBL] [Abstract][Full Text] [Related]
9. Failure matters: unsuccessful cytogenetics and unperformed cytogenetics are associated with a poor prognosis in a population-based series of acute myeloid leukaemia.
Lazarevic V; Hörstedt AS; Johansson B; Antunovic P; Billström R; Derolf Å; Lehmann S; Möllgård L; Peterson S; Stockelberg D; Uggla B; Vennström L; Wahlin A; Höglund M; Juliusson G
Eur J Haematol; 2015 May; 94(5):419-23. PubMed ID: 25200361
[TBL] [Abstract][Full Text] [Related]
10. Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival.
Juliusson G; Billström R; Gruber A; Hellström-Lindberg E; Höglunds M; Karlsson K; Stockelberg D; Wahlin A; Aström M; Arnesson C; Brunell-Abrahamsson U; Carstensen J; Fredriksson E; Holmberg E; Nordenskjöld K; Wiklund F;
Leukemia; 2006 Jan; 20(1):42-7. PubMed ID: 16327841
[TBL] [Abstract][Full Text] [Related]
11. [Complex karyotype is a marker of very poor prognosis in over 70-year-old patients with acute myeloid leukemia and extended types of myelodysplastic syndrome and high comorbidity index].
Gritsaev SV; Martynkevich IS; Abdulkadyrov KM; Ivanova MP; Petrova EV; Zapreeva IM; Tiranova SA; Potikhonova NA
Ter Arkh; 2012; 84(7):16-21. PubMed ID: 23038966
[TBL] [Abstract][Full Text] [Related]
12. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
Willemze R; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T
J Clin Oncol; 2014 Jan; 32(3):219-28. PubMed ID: 24297940
[TBL] [Abstract][Full Text] [Related]
13. The response to induction therapy is crucial for the treatment outcomes of elderly patients with acute myeloid leukemia: single-institution experience.
Tasaki T; Yamauchi T; Matsuda Y; Takai M; Ookura M; Lee S; Tai K; Ikegaya S; Kishi S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Anticancer Res; 2014 Oct; 34(10):5631-6. PubMed ID: 25275066
[TBL] [Abstract][Full Text] [Related]
14. Benefit of allogeneic transplantation in patients age ≥ 60 years with acute myeloid leukemia is limited to those in first complete remission at time of transplant.
Michelis FV; Messner HA; Atenafu EG; Kim DD; Kuruvilla J; Lipton JH; Uhm J; Loach D; Gupta V
Biol Blood Marrow Transplant; 2014 Apr; 20(4):474-9. PubMed ID: 24345422
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia in the real world: why population-based registries are needed.
Juliusson G; Lazarevic V; Hörstedt AS; Hagberg O; Höglund M;
Blood; 2012 Apr; 119(17):3890-9. PubMed ID: 22383796
[TBL] [Abstract][Full Text] [Related]
16. Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: are they valuable factors for therapeutic decision-making?
Thomas X; Chelghoum Y; Cannas G; Elhamri M; Labussière H; Tigaud I; Ducastelle S; Nicolini F; Dumontet C; Michallet M
Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):342-9. PubMed ID: 21816372
[TBL] [Abstract][Full Text] [Related]
17. Elderly patients with acute myeloid leukaemia: characteristics in biology, patients and treatment. Recommendations of the Working Group Geriatric Oncology of the German Society for Haematology and Oncology (DGHO), the Austrian Society for Haematology and Oncology (OGHO) and the German Society for Geriatrics (DGG).
Wedding U; Bokemeyer C; Meran JG; ; ;
Onkologie; 2004 Feb; 27(1):72-82. PubMed ID: 15007253
[TBL] [Abstract][Full Text] [Related]
18. [Should patients over 65 years old with acute myeloid leukemia be treated with myelosuppressive chemotherapy?].
Spataro V; Cometta A; Glauser MP; Schapira M; Grob JP
Schweiz Med Wochenschr; 1995 Mar; 125(9):429-32. PubMed ID: 7892571
[TBL] [Abstract][Full Text] [Related]
19. Current and emerging therapies for acute myeloid leukemia.
Robak T; Wierzbowska A
Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
[TBL] [Abstract][Full Text] [Related]
20. Treatment of elderly patients with AML: results of an individualized approach.
Hernández-Boluda JC; Sierra J; Esteve J; Nomdedeu B; Montserrat E
Haematologica; 1998 Jan; 83(1):34-9. PubMed ID: 9542321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
